mycosis fungoides


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Translations

mycosis fungoides

n micosis f fungoide
Mentioned in ?
References in periodicals archive ?
Reassessment of lymphocyte immunophenotyping in the diagnosis of patch and plaque stage lesions of mycosis fungoides.
The ongoing phase II clinical trial is enrolling CTCL patients with mycosis fungoides (MF) or Sezary syndrome.
Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma.
This latest set of duration of response data is very encouraging and indicates that HuMax-CD4 may be effective in treating CTCL patients with mycosis fungoides, especially at higher doses," said Lisa N.
Food and Drug Administration (FDA) for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL).
Genmab A/S announced today additional encouraging duration of response data from one of its HuMax-CD4 (zanolimumab) Phase II studies treating patients with mycosis fungoides (MF) a type of cutaneous T-cell lymphoma (CTCL).
marketing approval for topical treatment for early stage (stages I-IIA) mycosis fungoides, a common type of Cutaneous T-Cell Lymphoma -
Yaupon recently submitted a New Drug Application (NDA) to the FDA for a proprietary gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, the most common type of cutaneous T-cell lymphoma (CTCL).
This duration of response data is based on an analysis of responding mycosis fungoides (MF) patients at all dose levels, 280, 560 and 980 mg.
marketing approval for the topical treatment of early stage (stages I-IIA) mycosis fungoides, a common type of Cutaneous T-Cell Lymphoma -
New management to focus on NDA submission for proprietary gel formulation of mechlorethamine hydrochloride to treat early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma -
The most predominant type of CTCL is Mycosis Fungoides (MF).